Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/19/2010WO2010091543A1 Novel hydrazino-cyclobut-3-ene-1, 2-dione derivatives as cxcr2 antagonists
08/19/2010WO2010091489A1 Pharmaceutical composition and its use for treatment and/or prevention of diseases of the respiratory tract
08/19/2010WO2010091488A1 Composition containing vegetable oil and resveratrol, method for producing same and nutraceuticals containing said composition
08/19/2010WO2010091472A1 Skin treatment
08/19/2010WO2010077671A3 Stable perfluorocarbon emulsion for use as an artificial oxygen carrier
08/19/2010WO2010075347A3 Treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone
08/19/2010WO2010075280A3 Coumarin-based compounds for the treatment of alzheimer's disease and cancer
08/19/2010WO2010075263A3 Compounds and methods for enhancing erythropoiesis
08/19/2010WO2010075255A3 Methods for treating or preventing cancer and neurodegenerative diseases
08/19/2010WO2010074776A3 Compounds for the treatment of cancer
08/19/2010WO2010074607A3 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
08/19/2010WO2010073126A3 Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof
08/19/2010WO2010072734A3 Targeting prodrugs and compositions for the treatment of gastrointestinal diseases
08/19/2010WO2010072647A3 Dihydropyridone amides useful as medicaments for the treatment of autoimmune and inflammatory diseases
08/19/2010WO2010072420A3 Compositions comprising hemp oil for treating topical diseases, especially hand-foot syndrome
08/19/2010WO2010070589A3 A novel dermaceutical cream made using sodium fusidate
08/19/2010WO2010070057A3 Precompacted fast-disintegrating formulations of compounds with a low oral bioavailability
08/19/2010WO2010066912A3 Compounds having activity in correcting mutant cftr cellular processing
08/19/2010WO2010066034A8 Narcotic drug formulations with decreased abuse potential
08/19/2010WO2010066028A8 3,4 - substituted piperidine derivatives as renin inhibitors
08/19/2010WO2010065861A3 Inhibitors of bace 1 and methods for treating alzheimer's disease
08/19/2010WO2010062581A3 A botanical composition for enhanced skin repair and uses thereof
08/19/2010WO2010062144A3 Ethacrynic acid-containing composition and method for prevention and treatment of transglutaminase-related diseases
08/19/2010WO2010061220A3 Novel processes and pure polymorphs
08/19/2010WO2010061185A3 Carbonic anhydrase inhibitors for treating dandruff and related disorders
08/19/2010WO2010060041A3 Phenylalanine amide inhibitors of atp-sensitive potassium channels
08/19/2010WO2010058936A3 Skin external composition for inhibiting epidermal hyperproliferation and alleviating inflammatory skin diseases containing ortho-dihydroxyisoflavone derivatives
08/19/2010WO2010056985A9 Treatment of proteinopathies using a farnesyl transferase inhibitor
08/19/2010WO2010056754A3 Inhibition of mammalian target of rapamycin
08/19/2010WO2010055027A3 Salts of fingolimod
08/19/2010WO2010054858A3 Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens
08/19/2010WO2010054381A3 Method of treating cancer with a combination of a proteasome inhibitor and salubrinal
08/19/2010WO2010054331A4 Microrna-mediated regulation of ubc9 expression in cancer cells
08/19/2010WO2010054158A3 Steroid modulators of glucocorticoid receptor
08/19/2010WO2010054114A3 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
08/19/2010WO2010054113A3 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
08/19/2010WO2010054068A3 Cyclic adenosine monophosphates for reducing the formation of adhesions
08/19/2010WO2010054001A3 D-tagatose-based compositions and methods for preventing and treating atherosclerosis, metabolic syndrome, and symptoms thereof
08/19/2010WO2010053306A3 Pharmaceutical composition for the controlled release of methylphenidate
08/19/2010WO2010048273A3 Methods and compounds for treatment of neurodegenerative disorders
08/19/2010WO2010048264A3 Methods and compositions for the treatment of immunoinflammatory disorders
08/19/2010WO2010047774A3 Inhibitors of mycobacterium tuberculosis malate synthase, methods of marking and uses thereof
08/19/2010WO2010047500A3 Composition for prevention or treatment of eye diseases
08/19/2010WO2010045542A3 Fused ring heteroaryl kinase inhibitors
08/19/2010WO2010045276A3 Azabenzimidazolones
08/19/2010WO2010045209A9 Methods of treating pulmonary disorders with liposomal amikacin formulations
08/19/2010WO2010044637A3 Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-iv, and other antidiabetic or antiobesity agents as active ingredients
08/19/2010WO2010044070A3 Synergistic composition for recovery and reduction of mild ischemic damage
08/19/2010WO2010042780A3 Methods and compositions for treating status epilepticus and seizures causing status epilepticus
08/19/2010WO2010042636A3 Telomerase inhibitors and methods of use thereof
08/19/2010WO2010042500A3 Heat shock protein 90 inhibitors, methods of preparing same, and methods for their use
08/19/2010WO2010042229A3 Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3)
08/19/2010WO2010039861A3 Dendrimer conjugates
08/19/2010WO2010039798A3 Amorphous compositions of sunitinib base and l-malic acid
08/19/2010WO2010039534A3 Viral and fungal inhibitors
08/19/2010WO2010033495A3 Functionally selective azanitrile alpha2c adrenoreceptor agonists
08/19/2010WO2010033198A3 Analogs of indole-3-carbinol and their use as agents against infection
08/19/2010WO2010026596A3 Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses
08/19/2010WO2010023274A3 Composition for the treatment of alopecia
08/19/2010WO2010023197A3 Piperidine-4-acetamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/19/2010WO2010023196A3 Piperidylpropionamide derivatives useful for the treatment of cns disorders including depression and panic disorder
08/19/2010WO2010018175A3 Oral pharmaceutical formulation for omeprazole comprising a specific separation layer
08/19/2010WO2010004584A3 Process for production of anti-diabetic compound in root culture of catharanthus roseus
08/19/2010WO2009152917A3 Stabilization of the composition of a mixture
08/19/2010WO2009122034A8 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
08/19/2010WO2009064747A3 4(-3-(-2-(phenyl) morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazol-2-yl) benzenesulfon amide derivatives and related compounds as modulators of ion channels for the treatment of pain
08/19/2010WO2009061453A8 Solubilized thiazolopyridines
08/19/2010US20100212037 Mia-2 protein
08/19/2010US20100212036 Selective inhibition of histone deacetylases 1 and 2 as a treatment for cardiac hypertrophy
08/19/2010US20100212033 Novel ubiquitin lifases as therapeutic tragets
08/19/2010US20100211410 Customizable Handheld Computer Data Collection System
08/19/2010US20100211137 Acne therapeutic agent and sebum secernent inhibitor which comprise indole-3-alkylcarbo xylicacid, and kits for photodynamic therapy containing the same
08/19/2010US20100211072 Composition for In Vivo Vessel Repair
08/19/2010US20100211010 Topical anesthetic and antiseptic dispensing device
08/19/2010US20100210839 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/19/2010US20100210738 Prognostic biomarkers to predict overall survival and metastatic disease in patients with triple negative breast cancer
08/19/2010US20100210735 Modulating the Activity of Nuclear Receptors in Order to Treat Hypoxia-Related Disorders
08/19/2010US20100210734 Method of using calcitriol for treating intraocular diseases associated with angiogenesis
08/19/2010US20100210733 Composition for Prevention or Treatment of Bone Metabolism Disorder Comprising D-Pinitol as an Active Ingredient
08/19/2010US20100210732 Methods of Preventing the Serotonin Syndrome and Compositions for Use Therefor
08/19/2010US20100210731 Modafinil Compositions
08/19/2010US20100210730 N-halogenated amino acid formulations with anti-inflammatory compounds
08/19/2010US20100210729 Methods of inducing terminal differentiation
08/19/2010US20100210728 Composition for treating a dermal anomaly
08/19/2010US20100210727 Hepoxilin analog enantiomers
08/19/2010US20100210726 Composition for promoting ketone body production
08/19/2010US20100210723 Lipase inhibitor
08/19/2010US20100210722 Composition for preventing or treating lipid metabolic disorders comprising fucoxanthin or marine plant extract containing same
08/19/2010US20100210720 Preservative-free prostaglandin-based ophthalmic solution
08/19/2010US20100210719 O-desmethylvenlafaxine
08/19/2010US20100210718 Synergistic anti-oxidant treatment for lipotoxicity and other metabolically related phenomena
08/19/2010US20100210717 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
08/19/2010US20100210716 Process for Preparing an Alpha-Lipoic Acid/Cyclodextrin Complex and Product Prepared
08/19/2010US20100210715 Biodegradable cationic polymers
08/19/2010US20100210714 Her-2/neu DNA Vaccine Having Anti-Cancer Activity
08/19/2010US20100210713 Regeneration and survival of cardiac progenitors and cardiomyocytes with a stretch activated transcription factor
08/19/2010US20100210712 Short RNA Antagonist Compounds for the Modulation of Target mRNA
08/19/2010US20100210711 Methods and Compositions for the Treatment of Sterile Inflammation
08/19/2010US20100210710 THERAPEUTIC siRNA MOLECULES FOR REDUCING VEGFR1 EXPRESSION IN VITRO AND IN VIVO
1 ... 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 ... 7860